Reply to: “correspondence about “Efficacy and safety of basiliximab”
oleh: Mohamed Hashim, Ayman Alsebaey, Amr Ragab, Hossam Eldeen Soliman, Imam Waked
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2022-03-01 |
Deskripsi
No description available for this item.